ICPE 2022
Description: European full-service Contract Research Organization (CRO) delivering observational studies for safety, market access and drug development.
We offer a combination of world-class science, operations and technology to provide large and small pharma companies worldwide with real-world evidence for safety, market access and drug development.
This cohort study clarifies the conflicting evidence of previous studies and identifies which lipid fractions are modifiable risk factors for Alzheimer´s dementia and which are not.
Primary data collection and secondary data observational studies, synthesis research and statistics, data analysis & modelling
ICPE 2022